Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Hormones and the Endocrine System >  Androgen and anabolic hormones >  Fluoxymesterone

Fluoxymesterone

Basic information Safety Supplier Related

Fluoxymesterone Basic information

Product Name:
Fluoxymesterone
Synonyms:
  • 11-beta,17-beta-Dihydroxy-9-alpha-fluoro-17-alpha-methyl-4-androster-3-one
  • 17-alpha-methyl-9-alpha-fluoro-11-beta-hydroxytesterone
  • 17-alpha-Methyl-9-alpha-fluoro-11-beta-hydroxytestosterone
  • 9-alpha-fluoro-11-beta,17-beta-dihydroxy-17-alpha-methyl-4-androstene-3-one
  • 9alpha-Fluoro-11beta,17beta-dihydroxy-17alpha-methyl-4-androstene-3-one
  • 9-alpha-fluoro-11-beta-hydroxy-17-methyltestosterone
  • 9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone
  • 9-alpha-Fluoro-17-alpha-methyl-11-beta,17-dihydroxy-4-androsten-3-one
CAS:
76-43-7
MF:
C20H29FO3
MW:
336.44
EINECS:
200-961-8
Product Categories:
  • Steroids
  • Organics
  • chiral
  • Intermediates & Fine Chemicals
  • teroids
  • Inhibitors
  • Steroid and Hormone
  • Pharmaceuticals
  • API
  • 76-43-7
Mol File:
76-43-7.mol
More
Less

Fluoxymesterone Chemical Properties

Melting point:
240 °C
alpha 
104 º (c=1,EtOH)
Boiling point:
474.2±45.0 °C(Predicted)
Density 
1.0455 (estimate)
storage temp. 
-20°C
solubility 
H2O: ≤0.5 mg/mL
form 
solid (photosensitive)
pka
13.40±0.70(Predicted)
color 
white
Water Solubility 
NEGLIGIBLE
Merck 
13,4212
InChI
InChI=1/C20H29FO3/c1-17-8-6-13(22)10-12(17)4-5-15-14-7-9-19(3,24)18(14,2)11-16(23)20(15,17)21/h10,14-16,23-24H,4-9,11H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/s3
InChIKey
YLRFCQOZQXIBAB-MGWAJYFFNA-N
SMILES
[C@]12(F)[C@@H](O)C[C@]3(C)[C@](CC[C@@]3([H])[C@]1([H])CCC1=CC(=O)CC[C@]21C)(O)C |&1:0,2,5,7,10,12,22,r|
CAS DataBase Reference
76-43-7(CAS DataBase Reference)
NIST Chemistry Reference
4-Androsten-3-one, 9alpha-fluoro-11beta,17beta-dihydroxy-17alpha-methyl-,(76-43-7)
EPA Substance Registry System
Fluoxymesterone (76-43-7)
More
Less

Safety Information

Hazard Codes 
Xn,T,F
Risk Statements 
63-38-19-11-61-60
Safety Statements 
22-36-24/25-45-53
WGK Germany 
3
RTECS 
BV8390000
HS Code 
29372900
Hazardous Substances Data
76-43-7(Hazardous Substances Data)
Toxicity
LD50 intraperitoneal in mouse: 2350mg/kg

MSDS

More
Less

Fluoxymesterone Usage And Synthesis

Description

Fluoxymesterone(Halotestin) is a steroid with an androgenic property that is used in primary hypogonadism and testicular failure due to cryptorchidism, vanishing testes syndrome, or orchidectomy; and in hypogonadotrophic hypogonadism and luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary hypothalamic injury from tumors, trauma, or radiation. It mimics the actions of testosterone, which is responsible for normal growth and development of the male sex organs and for the maintenance of secondary sex characteristics. In female postmenopausal patients, fluoxymesterone may be indicated in the palliation of recurrent mammary cancer.

Chemical Properties

white to light yellow crystal powder

Originator

Halotestin, Upjohn, US,1957

Uses

Fluoxymesterone is an anabolic steroid with androgenic activity. It is used in the treatment of male hypogonadism. It showed antitumor effects on pregnancy-dependent mammary tumors TPDMT-4.

Indications

Fluoxymesterone promotes growth and development of male reproductive organs, maintains secondary sex characteristics, increases protein anabolism, and decreases protein catabolism. It is used to treat symptoms of low testosterone in adult men who have hypogonadism (a condition in which the body does not produce enough natural testosterone). It is also used for palliation of androgen-responsive recurrent mammary cancer in women who are more than 1 year but less than 5 years postmenopausal (women).

Definition

ChEBI: Fluoxymesterone is an anabolic androgenic steroid, a 17beta-hydroxy steroid, an 11beta-hydroxy steroid, a fluorinated steroid and a 3-oxo-Delta(4) steroid. It has a role as an antineoplastic agent and an anabolic agent.

brand name

Android (Valeant); Halotestin (Pharmacia & Upjohn); Ora-Testryl (Bristol-Myers Squibb).

Therapeutic Function

Androgen

General Description

Fluoxymesterone, 9α-fluoro-11β,17β-dihydroxy-17-methylandrost-4-en-3-one, is ahighly potent, orally active androgen, about 5 to 10 timesmore potent than testosterone. It can be used for all theindications discussed previously, but its great androgenicactivity has made it useful primarily for treatment of theandrogen-deficient male.

Pharmacokinetics

By substituting a 9α-fluoro group onto an analog of 17α-methyltestosterone, fluoxymesterone has 20 times the anabolic and 10 times the androgenic activity of 17α-methyltestosterone. It has a mean half-life of 9 hours, and less than 5% of the drug is excreted unchanged. An adverse effect of fluoxymesterone is sodium and water retention that could lead to edema.

Side effects

Fluoxymesterone is used as an androgen hormonal supplement. An adverse effect of fluoxymesterone is sodium and water retention that could lead to edema. Side effects associated with this agent include closing of the epiphyseal closures, hypercalcemia, and edema. This product should not be given to boys who are in puberty because of its effect on the epiphyseal closures.

Safety Profile

Fluoxymesterone is contraindicated in male subjects with known or suspected carcinoma of the prostate gland. Prolonged use of high-dosage 17-alpha-alkyl androgens is known to have caused hypercalcemia, hepatic adenoma, hepatocellular carcinoma, and hepatitis. Fluoxymesterone, which accelerates bone maturation without producing linear growth, should be used cautiously in males with delayed puberty. Edema and CHF may occur in patients with preexisting cardiovascular problems. Androgens cause virilization in female subjects.

Synthesis

Fluoxymesterone, 9-fluoro-11|?,17|?-dihydroxy-17|á-methylandrost- 4-en-3-one (29.3.8), is made from 11|?-hydroxy-4-androsten-3,17-dione, which is reacted with pyrrolidine to give a dieneamine (29.3.4). This undergoes a reaction with methylmagnesiumiodide, which after hydrolysis forms 11|?,17|?-dihydroxy-17|á-methylandrost- 4-en-3-one (29.3.5). Dehydration of this compound by selective tosylation of the secondary hydroxyl group at C11 using p-toluenesulfonyl chloride and subsequent reaction with a base gives the diene (29.3.6), and the double bond at C9¨CC11 is transformed to an epoxide (29.3.7) by subsequent reaction with N-bromoacetamide in a wet solvent (source of HOBr), and a base. Further reaction with hydrogen fluoride results in an opening of the epoxide ring and the formation of the desired fluoxymesterone (29.3.8).

Mode of action

Fluoxymesterone binds to androgen receptors, suppressing GnRH, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) through a negative feedback mechanism involving the hypothalamus and anterior pituitary. It antagonizes the estrogenic effects in estrogendependent target cells.

FluoxymesteroneSupplier

Jinhua Fanshuo Biological Technology Co. LTD Gold
Tel
18838946306
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
Email
sales@capotchem.com
LGM Pharma
Tel
1-(800)-881-8210
Email
inquiries@lgmpharma.com
Sinopharm Chemical Reagent Co,Ltd.
Tel
86-21-63210123
Email
sj_scrc@sinopharm.com